Automated GMP-compliant PSC banking in a closed system

Chao performed his Ph.D. projects at the Chinese Academy of Sciences in Beijing, China, and then continued his Postdoc studies at the University of Bonn and the German Center for Neurodegenerative Diseases in Bonn, Germany, focusing on cell fate (re)programming. Chao joined Miltenyi Biotec as a Product Manager for the Regenerative Medicine portfolio in 2018. He and his colleagues are developing automated, closed, and scalable adherent stem cell cultivation technologies based on the widely used CliniMACS Prodigy® Cell Manufacturing Platform.

Rafal has obtained a M.D. degree in 1996 and worked as a pediatric surgeon at the Medical University of Lódz, Poland.In 2005, he received a Japanese MEXT scholarship and started a doctoral course at Kobe University, where he became first interested in induced pluripotent stem cells (iPS cells).After obtaining the Ph.D. degree in 2010, he held several postdoctoral positions in Japan and received an iPS cell generation and maintenance training at Kumamoto University.In January 2019, he joined the Research and Development Section in Facility for iPS Cell Therapy, Center for iPS Cell Research and Application, Kyoto University, headed by Prof. Shinya Yamanaka, where he is working on the manufacturing of iPS cells for clinical applications.In 2020, the facility became a core of newly established CiRA Foundation (https://www.cira-foundation.or.jp/e/), which is a public interest incorporated foundation intended to serve as a bridge between academia and industry.